首页> 外文期刊>Arthritis & rheumatology. >Deletion of Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis
【24h】

Deletion of Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis

机译:在小鼠T细胞中缺失粘膜相关淋巴组织淋巴瘤相关蛋白粘膜相关淋巴组织1淋巴瘤易位蛋白1,可防止自身免疫性关节炎的发育,但导致自发性骨质疏松症

获取原文
获取原文并翻译 | 示例
       

摘要

Objective Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 ( MALT ‐1) plays a crucial role in innate and adaptive immune signaling by modulating the threshold for activation of immune cells, including Treg cells. Therefore, MALT ‐1 is regarded to be an interesting therapeutic target in several immune‐mediated diseases. The goal of this study was to examine the role of MALT ‐1 in experimental animal models of rheumatoid arthritis ( RA ). Methods MALT ‐1 activation was assessed by measuring cleavage of the deubiquitinase CYLD in lymphocytes from mice with collagen‐induced arthritis ( CIA ). Furthermore, the impact of MALT ‐1 deficiency on arthritis was evaluated in Malt1 KO mice with CIA or with collagen antibody–induced arthritis ( CAIA ). T cell–specific MALT ‐1 deficiency was measured in mice with deletion of T cell–specific MALT‐1 ( Malt1 Tcell KO ), and the time‐dependent effects of MALT ‐1 deficiency were assessed in mice with deletion of tamoxifen‐inducible T cell–specific MALT‐1 ( Malt1 iTcell KO ). Bone density was determined in MALT ‐1–deficient mice using micro–computed tomography and femur‐bending tests. Reconstitution of Treg cells was performed using adoptive transfer experiments. Results MALT ‐1 activation was observed in the lymphocytes of mice with CIA . T cell–specific MALT ‐1 deletion in the induction phase of arthritis (incidence of arthritis, 25% in control mice versus 0% in Malt1 iTcell KO mice; P 0.05), but not in the effector phase of arthritis, completely protected mice against the development of CIA . Consistent with this finding, MALT ‐1 deficiency had no impact on CAIA , an effector phase model of RA . Finally, mice with MALT ‐1 deficiency showed a spontaneous decrease in bone density (mean ± SEM trabecular thickness, 46.3 ± 0.7 μm in control mice versus 40 ± 1.1 μm in Malt1 KO mice; P 0.001), which was linked to the loss of Treg cells in these mice. Conclusion Overall, these data in murine models of RA highlight MALT ‐1 as a master regulator of T cell activation, which is relevant to the pathogenesis of autoimmune arthritis. Furthermore, these findings show that MALT ‐1 deficiency can lead to spontaneous osteoporosis, which is associated with impaired Treg cell numbers.
机译:目的粘膜相关淋巴组织淋巴瘤转移蛋白1(MALT -1)通过调节免疫细胞的激活阈值,在先天和适应性免疫信号传导中起着至关重要的作用,包括Treg细胞。因此,麦芽-1被认为是几种免疫介导的疾病中有趣的治疗靶标。本研究的目的是研究MALT -1在类风湿性关节炎(RA)实验动物模型中的作用。方法通过测量来自胶原诱导的关节炎(CIA)的小鼠的淋巴细胞中脱水素酶CULD的脱硫酶CULD的切割来评估MALT -1活化。此外,麦芽-1缺乏对关节炎的影响是在MALT1 KO小鼠中评估了CIA或胶原蛋白抗体诱导的关节炎(CAIA)。在小鼠中测量特异性麦芽-1缺乏,缺失T细胞特异性麦芽-1(Malt1 Tcell Ko),并且在小鼠中评估了麦芽-1缺乏的时间依赖性作用,缺失Tamoxifen-Inducible T.特定细胞麦芽-1(Malt1 Itcell Ko)。使用微计算机断层扫描和股骨弯曲试验在麦芽-1缺陷小鼠中测定骨密度。使用过继转移实验进行Treg细胞的重构。结果在CIA的小鼠淋巴细胞中观察到麦芽-1活化。 T细胞特异性麦芽-1在关节炎的诱导阶段(关节炎发生率,对照小鼠的25%在Malt1 Itcell Ko小鼠中的0%; P <0.05),但不在关节炎的效应阶段,完全保护针对CIA的发展的小鼠。与此发现一致,麦芽-1缺乏对疾病的影响,RA的效应相模型没有影响。最后,具有麦芽-1缺陷的小鼠显示出骨密度的自发性降低(平均±SEM厚度,对照小鼠的46.3±0.7μm,MALT1 KO小鼠的40±1.1μm; P <0.001),与之相关联这些小鼠中的Treg细胞丧失。结论总体而言,RA鼠标模型的这些数据突出显示MALT -1作为T细胞活性的母稳压器,与自身免疫性关节炎的发病机制有关。此外,这些研究结果表明,麦芽-1缺乏会导致自发性骨质疏松症,其与Treg细胞数有关。

著录项

  • 来源
    《Arthritis & rheumatology.》 |2019年第12期|共11页
  • 作者单位

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation ResearchGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    Ghent UniversityGhent Belgium;

    Ghent UniversityGhent Belgium;

    Ghent UniversityGhent Belgium;

    Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

    VIB‐UGent Center for Inflammation Research and Ghent UniversityGhent Belgium;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 全身性疾病;
  • 关键词

  • 入库时间 2022-08-20 01:27:00

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号